Medical treatment cost for Chinese inpatients with colorectal cancer by sites
Targeted programs for the management and treatment of various tumor sites should be considered, as rectal cancer costs are more stage-sensitive than colon cancer. The large proportion of costs attributed to medication, materials, and examinations provides guidance to the government in regulating the healthcare market to alleviate the economic burden of CRC.
Authors
- Huijuan Mao (ORCID: https://orcid.org/0000-0003-0422-0660)
- Xiaoyu Dai (ORCID: https://orcid.org/0000-0001-7276-5190)
- Jian‐Jiong Li
- B. Chen
- Jin-Ying Huang
- Wu Zhou (ORCID: https://orcid.org/0000-0002-9202-1989)
- Hua Yu (ORCID: https://orcid.org/0000-0003-0411-1085)
- Hu Zhou (ORCID: https://orcid.org/0000-0002-7110-7185)
- Stuart McDonald
- Yi Lin
Institutions
- Ningbo University (CN)
- University of Nottingham Ningbo China (CN)
- Ningbo No. 2 Hospital (CN)
- Ningbo No.6 Hospital (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2025-06-11
- DOI
- https://doi.org/10.3389/fpubh.2025.1605887
- Citations
- 1
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Ningbo Municipal Bureau of Science and Technology